In reinstating human ADME to its portfolio, SGS strengths its ability to support drug development programmes with critical early clinical data. FANC approval enables SGS to reintroduce ¹⁴C human ADME ...
Roche has inked a deal to use Cerep’s BioPrint®, a homogenous pharmacology and ADME database. The BioPrint database is composed of three main data sets: chemical descriptors (structures and chemical ...
The effect of patient-to-patient variability in drug response on combination cancer therapies, from 1961 to today. A pilot, phase I clinical trial to determine the biological effects of ...
ANTWERP, BELGIUM, February 16, 2026 /EINPresswire.com/ — SGS today announced it has received formal approval from the Belgian Federal Agency for Nuclear Control ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results